---
$id: https://graph.org.ai/products/commodity/51391701
$type: Product
source: UNSPSC
code: "51391701"
title: "Butopamine"
class: "51391700"
classTitle: "Sympathomimetic or adrenergic amino alcohols"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butopamine

**UNSPSC Code**: 51391701
**Class**: [Sympathomimetic or adrenergic amino alcohols](Sympathomimetic or adrenergic amino alcohols.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZX7907IE2H, chemically known as benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, (r-(r*,r*)) but generally known as butopamine, which bears US NIH Compound Identifier 68556. European Medicines Agency schedules Butopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06031MIG. The term BUTOPAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BUTOPAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butopamine under HS 29225000 and SITC 51467. As of Q4 2014, BUTOPAMINE remains the US FDA Preferred Term for this commodity. Butopamine bears US NLM identifiers UMLS ID C0054265 and NCI Concept Code C81649. SMILES: OC(CNC(CCC1CCC(O)CC1)C)C1CCC(O)CC1.

